- Injective (INJ) climbed 5.1% after breaking above key technical resistance.
- Strong volume supports a potential move toward $5.30.
- Analysts highlight improving momentum despite macro risks.
Injective is posting one of the strongest short-term performances among major altcoins today.
While much of the cryptocurrency market remained subdued, INJ climbed more than 5% over the past 24 hours, supported by a decisive technical breakout and a sharp increase in trading activity.
The move has shifted focus to the next key resistance level at $5.30.
At the same time, improving on-chain metrics and renewed optimism among market analysts have added to the growing interest in the token.
Technical breakout puts $5.30 in focus
At press time, INJ traded around $5.02 after gaining 5.1% over the previous 24 hours.
The latest rally was largely driven by a breakout above the 30-day simple moving average near $4.85.
Buyers also pushed the token through the 50% Fibonacci retracement level around $5.06, a level that had capped previous recovery attempts.
The surge also stood out because it occurred while Bitcoin was slightly weaker during the same period, indicating that the latest advance was driven primarily by Injective’s own technical setup rather than broad market strength.
Unlike many short-lived price spikes, this breakout was accompanied by stronger participation from traders.
Daily trading volume rose by more than 26% to approximately $86.9 million, suggesting that the move was supported by fresh buying interest rather than weak liquidity.
The next level attracting attention now is the 38.2% Fibonacci resistance around $5.30.
Holding above the $4.85 breakout zone would keep that target in focus, while losing this level could expose the token to another test of support near $4.50.
On-chain activity continues to support the network
The recent price action also comes alongside several encouraging developments within the Injective ecosystem.
The network has processed more than $34 billion in derivatives trading volume, highlighting continued activity across its decentralised finance infrastructure.
At the same time, Injective has strengthened its stablecoin ecosystem through native USDC support, making it easier for users and developers to access on-chain liquidity.
Another closely watched metric is the Community Buyback mechanism.
More than 7.1 million INJ have now been permanently removed from circulation through the program, reinforcing the network’s long-term deflationary model.
The latest CoinGecko report puts Injective’s growth into perspective.
Top 10 L1 by protocol revenue, $34B+ in derivatives volume, native USDC, and 7.1M+ $INJ burned through the Community Buyback.$INJ keeps proving its strength with real onchain activity. @injective pic.twitter.com/Fe39MnS5Hm
— LOST CAT (@0x_Eligible) July 14, 2026
Protocol revenue has also remained among the strongest across Layer-1 blockchain networks, reflecting sustained activity rather than growth driven purely by speculation.
Although there were no major partnership announcements or protocol upgrades directly linked to the latest price increase, these on-chain metrics continue to provide additional context for the token’s recent resilience.
Analysts point to improving market structure
Market participants have also been watching several technical assessments published over the past few days.
Veteran financial trader Matthew Dixon said the broader cryptocurrency market could still form a meaningful low later in the year, but identified Injective as one of the stronger-looking altcoins.
According to Dixon, INJ established an important bottom between $2.60 and $2.80 before advancing toward the $6.80 to $7.00 area in what he described as a possible five-wave structure.
More importantly, the subsequent correction failed to create new lows and remained above major Fibonacci retracement levels, a pattern he considers healthier than that seen in many competing altcoins.
Dixon highlighted several important support levels for traders to monitor, including $4.57, $4.32, and $4.14. He also noted that the Relative Strength Index, or RSI, was hovering near 53, indicating that momentum was rebuilding instead of weakening.
Dixon added that if Bitcoin experiences another broad market decline of roughly 20%, Injective could revisit $3.75, with $3.40 representing a more extreme downside scenario during a wider market sell-off.
A separate chart shared by FurkanConsensus also pointed to improving long-term structure. The analyst identified a recurring liquidity and accumulation zone on the weekly chart that has repeatedly preceded major price moves.
Historical examples highlighted by FurkanConsensus include a rally of around 300% after a March 2023 retest of the zone and another advance of roughly 160% following about 70 days of accumulation between March and April 2026.
FurkanConsensus also noted that not every visit to the level immediately led to gains, citing November 2022, when the token briefly touched the area before declining further.
$INJ 1W Chart
I’m not sure, but it looks like the lines on the $INJ chart have been playing out pretty well. I also discovered a new level, which I’ve marked with the green line because it appears price has consistently visited this area for liquidity and accumulation.
Now… pic.twitter.com/VM3o26thZK
— FurkanConsensus 🦇🔊🍉 (@FurkanConsensus) July 13, 2026
Injective short-term outlook remains tied to key support
Despite the recent breakout, the next few trading sessions are likely to determine whether the move develops into a broader recovery.
Maintaining support above $4.85 would leave the door open for another attempt at $5.30, especially if trading volume remains elevated.
A successful move above that resistance could strengthen bullish momentum further.
However, traders should also watch broader market conditions closely.
The reaction to the latest US inflation data and Bitcoin’s ability to hold its own support levels may continue to influence sentiment across the altcoin market.
Markets,Injective Token#Injective #price #outlook #INJ #breakout #signals #upside #bulls #target1784029642
